Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
REPL | Replimune Group, Inc. | Chief Executive Officer, Director | $1.37 M | -$131 K | -8.7% | May 16, 2024 |
RVMD | Revolution Medicines, Inc. | Director | $767 K | -$79.7 K | -9.41% | Jun 20, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|